Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Russell's viper venom serine proteases (SVSPs) are a group of enzymatic toxins found in the venom of the Russell's viper (Daboia russelii), a snake of significant medical importance in South and Southeast Asia [1.1.1, 1.3.2]. The most prominent member of this family is the Factor V activator (RVV-V), which specifically cleaves and activates host coagulation Factor V, leading to the assembly of the prothrombinase complex and the rapid generation of thrombin [1.3.3, 1.4.1]. This procoagulant activity results in venom-induced consumptive coagulopathy (VICC), characterized by the depletion of clotting factors and a high risk of life-threatening hemorrhage or thrombosis [1.1.3, 1.4.3]. SVSPs are the primary targets of therapeutic antivenoms and are being investigated as targets for small-molecule inhibitors like nafamostat to improve treatment accessibility [1.2.1, 1.2.2]. Beyond their role in envenomation, these proteases are also employed as diagnostic reagents in the dilute Russell's Viper Venom Time (dRVVT) test to detect lupus anticoagulants in patient plasma [1.4.2].
Inhibition of the serine protease catalytic triad (His57, Asp102, Ser195) to prevent the proteolytic activation of Factor V and other coagulation factors, thereby inhibiting the formation of the prothrombinase complex and preventing venom-induced consumptive coagulopathy.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Russell's viper venom serine protease (RVV-SP).